دورية أكاديمية
أعرض في EDS

Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience.

التفاصيل البيبلوغرافية
العنوان: Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience.
المؤلفون: Herman WH; Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI, USA; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA. Electronic address: wherman@umich.edu., Villatoro C; Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI, USA., Joiner KL; Department of Health Behavior and Biological Sciences, School of Nursing, University of Michigan, Ann Arbor, MI, USA., McEwen LN; Department of Internal Medicine, Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, MI, USA.
المصدر: Journal of diabetes and its complications [J Diabetes Complications] 2023 Aug; Vol. 37 (8), pp. 108527. Date of Electronic Publication: 2023 Jun 08.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Pub. Co Country of Publication: United States NLM ID: 9204583 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-460X (Electronic) Linking ISSN: 10568727 NLM ISO Abbreviation: J Diabetes Complications Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Elsevier Science Pub. Co., c1992-
مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/epidemiology , Diabetes Mellitus, Type 2*/prevention & control , Prediabetic State*/complications , Prediabetic State*/epidemiology , Prediabetic State*/therapy, Adult ; Humans ; Glycated Hemoglobin ; Nitro Compounds ; Male ; Female
مستخلص: Aims: To evaluate retention and outcomes of insured adults with prediabetes who enrolled or did not enroll in National Diabetes Prevention Programs (NDPPs).
Methods: Between 2015 and 2019, 776 University of Michigan employees, dependents, and retirees with prediabetes and overweight or obesity enrolled in one-year NDPPs.
Results: Enrollees attended a median of 18 sessions. Median retention was 38 weeks. Retention was associated with older age, greater initial weight loss, and physical activity. At both 1- and 2-years, body mass index, triglycerides, and HbA1c were significantly improved among enrollees. After adjusting for age group, sex, and race, the odds of developing diabetes based on HbA1c ≥6.5 % was 40 % lower at 1-year and 20 % lower at 2-years, and the odds of self-reported diabetes was 57 % lower at 1-year and 46 % lower at 2-years in enrollees compared to non-enrollees. Enrollees who disenrolled before completing the core curriculum had higher odds and enrollees who completed the NDPP had lower odds of developing diabetes that non-enrollees.
Conclusions: In this population with prediabetes, NDPP retention was generally good, risk factors were improved, and diabetes was delayed or prevented for up to two years.
Competing Interests: Declaration of competing interest No potential conflicts of interest were reported.
(Copyright © 2023. Published by Elsevier Inc.)
References: Diabetes Care. 2020 Sep;43(9):2042-2049. (PMID: 32616617)
J Diabetes Res. 2022 Feb 1;2022:2942918. (PMID: 35118160)
J Diabetes Complications. 2022 Jul;36(7):108220. (PMID: 35613987)
Diabetes Care. 2017 Oct;40(10):1331-1341. (PMID: 28500215)
Ann Intern Med. 2005 Mar 1;142(5):323-32. (PMID: 15738451)
Diabetes Care. 2023 Feb 1;46(2):255-261. (PMID: 36701592)
JAMA Netw Open. 2019 May 3;2(5):e193160. (PMID: 31074808)
Am J Prev Med. 2013 Apr;44(4 Suppl 4):S346-51. (PMID: 23498297)
Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75. (PMID: 26377054)
Lancet Reg Health Eur. 2022 May 29;19:100420. (PMID: 35664052)
JAMA Intern Med. 2017 Dec 1;177(12):1808-1817. (PMID: 29114778)
N Engl J Med. 2002 Feb 7;346(6):393-403. (PMID: 11832527)
Diabetes Care. 2018 Jul;41(7):1526-1534. (PMID: 29934481)
Diabetes Care. 2021 Jul;44(7):1532-1539. (PMID: 34016617)
معلومات مُعتمدة: P30 DK020572 United States DK NIDDK NIH HHS; R01 DK109995 United States DK NIDDK NIH HHS; U18 DP006712 United States DP NCCDPHP CDC HHS
فهرسة مساهمة: Keywords: Diabetes incidence; Lifestyle intervention; Prediabetes; Prospective observational study; Retention; Type 2 diabetes prevention
المشرفين على المادة: 2138-40-1 (4-nitro-3-dimethylaminopropiophenone)
0 (Glycated Hemoglobin)
0 (Nitro Compounds)
تواريخ الأحداث: Date Created: 20230717 Date Completed: 20230811 Latest Revision: 20240807
رمز التحديث: 20240807
مُعرف محوري في PubMed: PMC10928673
DOI: 10.1016/j.jdiacomp.2023.108527
PMID: 37459781
قاعدة البيانات: MEDLINE
الوصف
تدمد:1873-460X
DOI:10.1016/j.jdiacomp.2023.108527